Butterfly Network, Inc., a prominent player in the health care sector, has recently disclosed a short-selling position held by Walleye Capital LLC. This position, recorded on July 16, 2026, represents a modest fraction of the company’s issued share capital. The disclosure is part of routine regulatory reporting on net short positions in the United States and does not suggest any material change in the company’s financial status or outlook. No further details regarding the holder’s trading strategy or intent were provided in the announcement, and no additional commentary or analysis from company officials accompanied the disclosure.
Butterfly Network, Inc. is an American health care company specializing in the manufacturing of medical imaging devices. The company is renowned for its innovative portable ultrasound device technology, which integrates semiconductors, artificial intelligence, and cloud technology. This integration aims to make medical imaging accessible to a broader audience, serving customers globally through their website at www.butterflynetwork.com . The company is listed on the New York Stock Exchange, where it trades under the currency of USD.
As of August 18, 2026, the close price of Butterfly Network’s stock was $9.17. The company’s 52-week high was recorded at $10.05 on August 9, 2026, while the 52-week low was $1.39 on August 21, 2025. The market capitalization of Butterfly Network stands at approximately $2.44 billion USD. However, the company’s price-to-earnings ratio is currently at -30.48, reflecting its financial performance metrics.
Despite the recent disclosure of the short-selling position, Butterfly Network continues to focus on its mission to democratize medical imaging technology. The company’s commitment to innovation and accessibility remains a cornerstone of its business strategy, as it seeks to expand its global reach and impact in the health care sector.
